FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin

Article Link: FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin

INCHEON, South Korea & JERUSALEM–(BUSINESS WIRE) December 14, 2018 –Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Herzuma (trastuzumab-pkrb), a HER2/neu…

Source: FDA New Drug Approvals